Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16212 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Ryan J Keenan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Sleep Wake Disorders, Tauopathies, Orexin Receptors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alzheimer's Association.
Abstract (Originalsprache)
Background and Purpose Tau pathology contributes to a bidirectional relationship between sleep disruption and neurodegenerative disease. Tau transgenic rTg4510 mice model tauopathy symptoms, including sleep/wake disturbances, which manifest as marked hyperarousal. This phenotype can be prevented by early transgene suppression; however, whether hyperarousal can be rescued after onset is unknown. Experimental approach Three 8‐week experiments were conducted with wild‐type and rTg4510 mice after age of onset of hyperarousal (4.5 months): (1) Tau transgene suppression with doxycycline (200 ppm); (2) inactive phase rapid eye movement (REM) sleep enhancement with the dual orexin receptor antagonist suvorexant (50 mg·kg −1 ·day −1 ); or (3) Active phase non‐NREM (NREM) and REM sleep enhancement using the selective orexin 2 (OX 2 ) receptor antagonist MK‐1064 (40 mg·kg −1 ·day −1 ). Sleep was assessed using polysomnography, cognition using the Barnes maze, and tau pathology using immunoblotting and/or immunohistochemistry. Key Results Tau transgene suppression improved tauopathy and hippocampal‐dependent spatial memory, but did not modify hyperarousal. Pharmacological rescue of REM sleep deficits did not improve spatial memory or tau pathology. In contrast, normalising hyperarousal by increasing both NREM and REM sleep via OX 2 receptor antagonism restored spatial memory, independently of tauopathy, but only in male rTg4510 mice. OX 2 receptor antagonism induced only short‐lived hypnotic responses in female rTg4510 mice and did not improve spatial memory, indicating a tau‐ and sex‐dependent disruption of OX 2 receptor signalling. Conclusions and Implications Pharmacologically reducing hyperarousal corrects tau‐induced sleep/wake and cognitive deficits. Tauopathy causes sex‐dependent disruptions of OX 2 receptor signalling/function, which may have implications for choice of hypnotic therapeutics in tauopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
- Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Finance, Faculty of Business and Economics, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Bruce Lefroy Centre, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
- Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Ryan J Keenan, Daniel Hoyer, Laura H Jacobson
Förderung
- Alzheimer's Association
Zitieren
APA
Keenan, R. J., Daykin, H., Metha, J., Cornthwaite-Duncan, L., Wright, D. K., Clarke, K., Oberrauch, S., Brian, M., Stephenson, S., Nowell, C. J., Allocca, G., Barnham, K. J., Hoyer, D., & Jacobson, L. H. (2024). Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice. British Journal of Pharmacology. https://doi.org/10.1111/bph.16212
Vancouver
Keenan RJ, Daykin H, Metha J, Cornthwaite-Duncan L, Wright DK, Clarke K, et al. Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice. British Journal of Pharmacology. 2024. doi:10.1111/bph.16212
BibTeX
@article{Keenan2024,
author = {Keenan, Ryan J and Daykin, Heather and Metha, Jeremy and Cornthwaite-Duncan, Linda and Wright, David K and Clarke, Kyra and Oberrauch, Sara and Brian, Maddison and Stephenson, Sarah and Nowell, Cameron J and Allocca, Giancarlo and Barnham, Kevin J and Hoyer, Daniel and Jacobson, Laura H},
title = {Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16212}
}
EUVIMED